New Drug Review 2016

This article reviews five new agents approved by the FDA in the past year.


Biosimilars: Current Approvals and Pipeline Agents

To date, only four biosimilars have been approved in the U.S. (Zarxio, Inflectra, Erelzi, Amjevita), although many other agents are under development.

Medication Therapy Management in Hospitalized Elderly Patients: A Focus on OTC Agents

Despite widespread use, many patients and healthcare professionals are not fully aware of the potential adverse events associated with OTC drugs.

New Therapies Approved for Multiple Myeloma

Although multiple myeloma is incurable, several treatments are available, and the last two decades have seen great progress in understanding its biology and treatment.

Pseudofolliculitis Barbae: Prevention and Treatment

Pseudofolliculitis barbae (informally referred to as razor bumps) is a common, chronic, inflammatory skin condition that develops primarily as a result of shaving.

Review of Selected NMEs 2016

This article discusses five new molecular entities recently approved by the FDA.

In This Issue

Approval of Novel Drugs in 2015

The largest number of novel drugs approved (45) occurred in 2015, and this rate was a 9.1% increase over 2014.

Assessing Alzheimer’s Medications

Five FDA-approved treatments target the symptoms of this neurologic disease, with the primary goal of improving patients’ quality of life.

Bosentan 6.25 mg/mL Oral Suspension

Bosentan is classified as hazardous by NIOSH and should be handled accordingly.

Lethal High: Acetyl Fentanyl

New psychoactive substances such as acetyl fentanyl pose significant regulatory challenges at both the federal and the state level.

Symptomatic Bradycardia: Ophthalmic Beta-Blockers in Older Adults

Beta-blockade is one of the toxic systemic effects of ophthalmic timolol found to be stronger and longer- lasting in the elderly.

Will Pharmacists Fuel Biosimilars?

Pharmacists can build patient confidence about biosimilars, promoting access to more economical treatment.

Quick Poll

How often do you attend pharmacy conferences?


Jobs Powered By InPharmacyJobs